VYNE THERAPEUTICS INC. (VYNE) Operating cash flow 2016–2025
VYNE THERAPEUTICS INC. (VYNE) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$33.1MFY2025 · since FY2016: -$2.3M → -$33.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$33.1M | +2.5% |
| FY2024 | -$34.0M | -34.1% |
| FY2023 | -$25.3M | +13.2% |
| FY2022 | -$29.2M | +48.2% |
| FY2021 | -$56.4M | +58.9% |
| FY2020 | -$137.1M | -86.8% |
| FY2019 | -$73.4M | -6.9% |
| FY2018 | -$68.7M | -143.3% |
| FY2017 | -$28.2M | -1146.0% |
| FY2016 | -$2.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice